1. Detection and localization of early- and late-stage cancers using platelet RNA
- Author
-
In ’t Veld, Sjors G.J.G., Arkani, Mohammad, Post, Edward, Antunes-Ferreira, Mafalda, D'Ambrosi, Silvia, Vessies, Daan C.L., Vermunt, Lisa, Vancura, Adrienne, Muller, Mirte, Niemeijer, Anna Larissa N., Tannous, Jihane, Meijer, Laura L., Le Large, Tessa Y.S., Mantini, Giulia, Wondergem, Niels E., Heinhuis, Kimberley M., van Wilpe, Sandra, Smits, A. Josien, Drees, Esther E.E., Roos, Eva, Leurs, Cyra E., Tjon Kon Fat, Lee Ann, van der Lelij, Ewoud J., Dwarshuis, Govert, Kamphuis, Maarten J., Visser, Lisanne E., Harting, Romee, Gregory, Annemijn, Schweiger, Markus W., Wedekind, Laurine E., Ramaker, Jip, Zwaan, Kenn, Verschueren, Heleen, Bahce, Idris, de Langen, Adrianus J., Smit, Egbert F., van den Heuvel, Michel M., Hartemink, Koen J., Kuijpers, Marijke J.E., oude Egbrink, Mirjam G.A., Griffioen, Arjan W., Rossel, Rafael, Hiltermann, T. Jeroen N., Lee-Lewandrowski, Elizabeth, Lewandrowski, Kent B., De Witt Hamer, Philip C., Kouwenhoven, Mathilde, Reijneveld, Jaap C., Leenders, William P.J., Hoeben, Ann, Verdonck-de Leeuw, Irma M., Leemans, C. René, Baatenburg de Jong, Robert J., Terhaard, Chris H.J., Takes, Robert P., Langendijk, Johannes A., de Jager, Saskia C., Kraaijeveld, Adriaan O., Pasterkamp, Gerard, Smits, Minke, Schalken, Jack A., Łapińska-Szumczyk, Sylwia, Łojkowska, Anna, Żaczek, Anna J., Lokhorst, Henk, van de Donk, Niels W.C.J., Nijhof, Inger, Prins, Henk Jan, Zijlstra, Josée M., Idema, Sander, Baayen, Johannes C., Teunissen, Charlotte E., Killestein, Joep, Besselink, Marc G., Brammen, Lindsay, Bachleitner-Hofmann, Thomas, Mateen, Farrah, Plukker, John T.M., Heger, Michal, de Mast, Quirijn, Lisman, Ton, Pegtel, D. Michiel, Bogaard, Harm Jan, Jassem, Jacek, Supernat, Anna, Mehra, Niven, Gerritsen, Winald, de Kroon, Cornelis D., Lok, Christianne A.R., Piek, Jurgen M.J., Steeghs, Neeltje, van Houdt, Winan J., Brakenhoff, Ruud H., Sonke, Gabe S., Verheul, Henk M., Giovannetti, Elisa, Kazemier, Geert, Sabrkhany, Siamack, Schuuring, Ed, Sistermans, Erik A., Wolthuis, Rob, Meijers-Heijboer, Hanne, Dorsman, Josephine, Oudejans, Cees, Ylstra, Bauke, Westerman, Bart A., van den Broek, Daan, Koppers-Lalic, Danijela, Wesseling, Pieter, Nilsson, R. Jonas A., Vandertop, W. Peter, Noske, David P., Tannous, Bakhos A., Sol, Nik, Best, Myron G., Wurdinger, Thomas, Pharmaceutics, Sub Membrane Biochemistry & Biophysics, Afd Pharmaceutics, CCA - Imaging and biomarkers, CCA - Cancer Treatment and Quality of Life, CCA - Cancer biology and immunology, AII - Cancer immunology, Amsterdam Gastroenterology Endocrinology Metabolism, Graduate School, Pulmonology, Neurosurgery, Surgery, Obstetrics and Gynaecology, Oncogenomics, Amsterdam Neuroscience - Neurovascular Disorders, Amsterdam Neuroscience - Systems & Network Neuroscience, Biochemie, MUMC+: HVC Pieken Trombose (9), RS: Carim - B03 Cell biochemistry of thrombosis and haemostasis, Fysiologie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Medische Oncologie (9), Pathology, Otorhinolaryngology and Head and Neck Surgery, Pulmonary medicine, Laboratory Medicine, Amsterdam Neuroscience - Neurodegeneration, Medical oncology laboratory, Otolaryngology / Head & Neck Surgery, Urology, Neurology, Intensive care medicine, APH - Mental Health, APH - Personalized Medicine, Radiation Oncology, Hematology, Hematology laboratory, Amsterdam Neuroscience - Neuroinfection & -inflammation, ACS - Pulmonary hypertension & thrombosis, Internal medicine, Obstetrics and gynaecology, Human genetics, Amsterdam Neuroscience - Complex Trait Genetics, Amsterdam Reproduction & Development (AR&D), ACS - Atherosclerosis & ischemic syndromes, Translational Immunology Groningen (TRIGR), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Groningen Institute for Organ Transplantation (GIOT), Targeted Gynaecologic Oncology (TARGON), Pharmaceutics, Sub Membrane Biochemistry & Biophysics, and Afd Pharmaceutics
- Subjects
Cancer och onkologi ,Cancer Research ,liquid biopsy ,Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2] ,blood platelets ,Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9] ,Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14] ,lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4] ,TEP ,SDG 3 - Good Health and Well-being ,Oncology ,blood ,Cancer and Oncology ,Neoplasms ,Urological cancers Radboud Institute for Health Sciences [Radboudumc 15] ,Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15] ,Biomarkers, Tumor ,Humans ,cancer ,RNA ,early detection ,Nanomedicine Radboud Institute for Molecular Life Sciences [Radboudumc 19] ,Early Detection of Cancer ,Rare cancers Radboud Institute for Health Sciences [Radboudumc 9] - Abstract
Contains fulltext : 281792.pdf (Publisher’s version ) (Open Access) Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets are involved in cancer progression and are considered a promising biosource for cancer detection, as they alter their RNA content upon local and systemic cues. We show that tumor-educated platelet (TEP) RNA-based blood tests enable the detection of 18 cancer types. With 99% specificity in asymptomatic controls, thromboSeq correctly detected the presence of cancer in two-thirds of 1,096 blood samples from stage I-IV cancer patients and in half of 352 stage I-III tumors. Symptomatic controls, including inflammatory and cardiovascular diseases, and benign tumors had increased false-positive test results with an average specificity of 78%. Moreover, thromboSeq determined the tumor site of origin in five different tumor types correctly in over 80% of the cancer patients. These results highlight the potential properties of TEP-derived RNA panels to supplement current approaches for blood-based cancer screening.
- Published
- 2022